malondialdehyde has been researched along with Diabetic Glomerulosclerosis in 125 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (8.80) | 18.2507 |
| 2000's | 32 (25.60) | 29.6817 |
| 2010's | 70 (56.00) | 24.3611 |
| 2020's | 12 (9.60) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, L; Ma, H | 1 |
| Fu, L; Huang, X; Lin, Z; Qin, G; Zhang, J | 1 |
| Chen, B; Chen, J; Chen, S; Chen, ZQ; Gu, XL; Han, YL; Hu, J; Liang, FX; Luo, ZH; Wang, KX; Wu, S; Zhang, YL; Zhou, T | 1 |
| Alizadeh, S; Kheirollahi, A; Langroudi, FE; Narani, MS; Shokrpoor, S; Vatannejad, A | 1 |
| Sun, A; Xu, X; Yan, L | 1 |
| Aghadavod, E; Akasheh, N; Amirani, E; Asemi, Z; Banikazemi, Z; Gholriz Khatami, P; Shafabakhsh, R; Sharafati Chaleshtori, R; Soleimani, A | 1 |
| Chen, G; Du, JW; Fan, XY; Feng, J; Jin, YL; Nie, Q; Zheng, XP | 1 |
| Cai, R; Jiang, J | 1 |
| Bai, L; Li, J; Li, M | 1 |
| Imagawa, A; Jin, D; Takai, S; Terai, K; Watase, K | 1 |
| Bevoor, DB; Bukhari, SNA; Chitti, R; Gubbiyappa, KS; Hiremath, AR; Khan, T; Li, P; Singh, Y; SreeHarsha, N | 1 |
| Cui, J; Guo, G; Luo, Y; Wan, H; Xie, S; Zhou, G | 1 |
| Erjiong, H; Jian, P; Qihan, Z; Wei, L | 1 |
| Feizi, A; Ghiasvand, R; Miraghajani, M; Mirlohi, M; Zaghian, N | 1 |
| Meng, Q; Sha, J; Su, X; Sui, B; Zhang, C | 1 |
| Amirani, E; Asadi, A; Asemi, Z; Bahmani, F; Dastorani, M; Farzin, N; Moravveji, A; Naseri, A; Sharifi, N; Soleimani, A; Taghizadeh, M | 1 |
| Chen, Y; Wu, G; Xu, M | 1 |
| Jia, L; Lan, Y; Liu, H; Liu, M; Liu, W; Tian, C; Wang, W; Zhang, J; Zhu, Y | 1 |
| Dadras, F; Ghasemi, H; Kheiripour, N; Khoshjou, F; Ranjbar, A; Seif Rabiei, MA | 1 |
| Abd El-Hack, ME; Ahmed, SYA; Alagawany, M; El-Sayed, SAA; Farag, MR; Samak, DH | 1 |
| Fujihara, K; Furukawa, S; Iwasaki, H; Kobayashi, K; Sekiya, M; Shimano, H; Sugano, Y; Suzuki, H; Yahagi, N; Yatoh, S | 1 |
| Du, M; Kou, L; Liu, P; Shang, M; Wang, X; Yang, P; Zhang, B; Zhang, Y | 1 |
| Chen, L; Guo, X; Li, J; Li, W; Wang, L; Wang, Z; Zhang, H; Zhang, J; Zhao, D | 1 |
| Asemi, Z; Emam-Djomeh, Z; Mazruei Arani, N; Sharafati-Chaleshtori, R; Soleimani, A; Tavakolipour, H | 1 |
| Ahmad, J; Alam, K; Arafat, MY; Arif, Z; Neelofar, K | 1 |
| Elbe, H; Guclu, MM; Gunaltili, M; Parlakpinar, H; Polat, A; Tutun, B; Vardi, N; Yasar, EN | 1 |
| Jia, G; Jiang, T; Li, R; Li, X; Li, Y; Liu, Y; Wu, Y; Xiao, J; Xie, L; Xu, K; Xu, Z; Yuan, Y; Zhang, H; Zhong, X | 1 |
| Jiang, W; Li, W; Liu, D; Wang, R; Zhang, T; Zhao, C; Zuo, M | 1 |
| Bu, H; Guo, L; Wang, H; Xu, K | 1 |
| Cui, Y; Hua, Q; Li, N; Li, T; Zhao, M | 1 |
| Cardoso, SA; de Freitas, RB; de Oliveira, GP; Etienne, I; Lima, LM; Magalhães, LVB; Palotás, A | 1 |
| Han, W; Ni, Y; Olatunji, OJ; Pan, D; Qin, A; Wang, D; Wang, X; Xiao, F; Zhang, S | 1 |
| Bao, Y; Li, S; Liu, X; M, S; Sui, M; Xie, R; Yin, H; Zou, C | 1 |
| Miao, J; Wang, S; Zhang, W; Zhang, Y | 1 |
| Kim, MJ; Lim, Y | 1 |
| Aslan, A; Bakır, M; Bakır, TÖ; Çolak, S; Geyikoglu, F; Türkez, H | 1 |
| Agilli, M; Avci, E; Bilgi, C; Cakir, E; Cevher, SC; Yaman, H | 1 |
| Ates, B; Elbe, H; Esrefoglu, M; Taskapan, C; Vardi, N; Yologlu, S | 1 |
| Feng, L; Gu, J; Jia, X; Ma, L; Qin, D; Wu, C; Zhang, M | 1 |
| Altinoz, E; Cigremis, Y; Elbe, H; Oner, Z; Turkoz, Y | 1 |
| El-Moselhy, MA; Hofni, A; Khalifa, MM; Taye, A | 1 |
| Lee, MK; Liu, B; Liu, K; Lu, C; Lv, G; Lv, X; Wu, Y; Xu, H | 1 |
| Heeba, GH; Mahmoud, ME; Morsy, MA | 1 |
| Guo, Y; Liu, Y; Wang, Y | 1 |
| Amanda, OF; Andrajati, R; Manfaatun, A; Muris, RU; Ogino, K; Sakano, N; Saputri, DA; Sauriasari, R; Setiawan, H; Wang, DH | 1 |
| Bondor, CI; Ciorba Pop, M; Kacso, IM; Moldovan, D; Muresan, A; Potra, AR; Rusu, CC; Vladutiu, DS | 1 |
| An, ZM; Dong, XG; Guo, Y; Qin, T; Zhou, JL | 1 |
| El-Sherbiny, M; Elsherbiny, NM; Said, E | 1 |
| Choi, R; Chung, CH; Kim, BH; Kim, HS; Lee, ES; Lee, EY; Lee, MY; Nawaboot, J | 1 |
| Cao, A; Chen, X; Chu, S; Guo, H; Peng, W; Wang, L; Zhang, X | 1 |
| Guan, Y; Li, N; Ma, HJ; Tian, YM; Wang, S; Zhang, L; Zhang, Y | 1 |
| Elmas, O; Erbas, O; Yigitturk, G | 1 |
| Asemi, Z; Bahmani, F; Kia, M; Mohammadi, AA; Soleimani, A | 1 |
| Ahmed, S; Borgohain, MP; Choubey, A; Chowdhury, L; Kumar, S; Lahkar, M; Pant, R | 1 |
| Ma, TH; Shen, P; Wang, HG; Wang, XZ; Wu, SN; Xie, R; Yang, XZ; Zhang, H | 1 |
| Chen, J; Guan, X; Hu, J; Li, S; Li, X; Sun, X; Zhang, Q; Zhang, R; Zhu, Q | 1 |
| Boix García, L; Codoñer-Franch, P; Del Castillo Villaescusa, C; Hernández-Marco, R; Pons Morales, S; Valls Bellés, V | 1 |
| Hirasawa, Y; Ito, M; Kawasaki, Y; Kyuki, K; Matsui, Y; Nagamatsu, T; Sakai, T; Toyoshi, T; Yabuki, SY; Yamane, K | 1 |
| Chung, CH; Koh, JH; Koh, SB; Lee, EY; Lee, MY; Nam, SM; Park, JH; Shin, JY; Shin, YG | 1 |
| Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, DS; Kim, TW; Lee, SJ; Ryu, OH; Yoo, HJ | 1 |
| Chang, D; Guo, MY; Li, H; Liang, MH; Pan, HZ; Qu, NQ; Sui, H; Wu, WH; Zhang, L | 1 |
| Arcaya, JL; Carrizo, E; Mosquera, J; Pedreañez, A; Rincon, J; Viera, N | 1 |
| Cikim, G; Dogukan, A; Juturu, V; Komorowski, J; Ozercan, I; Sahin, K; Tuzcu, M | 1 |
| Aizawa, Y; Arozal, W; Kodama, M; Ma, M; Suzuki, K; Tachikawa, H; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K | 1 |
| Qi, XM; Shen, JJ; Su, J; Wu, YG; Zhang, JJ; Zhang, P | 1 |
| Cui, X; Li, W; Li, X; Sun, X; Zhu, Q | 1 |
| Chang, TI; Han, DS; Han, SH; Kang, EW; Kang, SW; Kim, DH; Kim, SH; Kwak, SJ; Lee, SH; Li, JJ; Nam, BY; Park, JT; Yoo, TH | 1 |
| Feng, B; Guo, YH; Liu, L; Luo, ZF; Mu, J; Pang, Q; Qi, W; Ye, ZL; Yuan, FH; Zeng, W | 1 |
| Ahmed, RS; Banerjee, BD; Datta, SK; Kalra, OP; Kumar, V; Pathak, R; Tripathi, AK | 1 |
| Chen, GR; Li, JM; Liu, Y; Mao, SZ; Zhen, CF | 1 |
| Ahmadvand, H; Delfan, B; Khalatbari, AR; Tamjidipoor, A; Tavafi, M | 1 |
| Cao, Y; Duan, H; Li, H; Liu, Q; Ren, Y; Shi, Y; Wang, F; Zhang, L | 1 |
| Cay, M; Ulas, M | 1 |
| Chen, X; Deng, Y; He, K; Huang, J; Jin, Q; Jin, Y; Li, P; Li, X; Shi, Q; Shu, H; Ye, X | 1 |
| Lei, J; Li, X; Xue, W; Zhang, R | 1 |
| Baker, NL; Carter, RE; Lachin, J; Lopes-Virella, MF; Virella, G | 1 |
| Cheng, YN; Gao, JJ; Jiao, B; Wang, YS; Zhang, QZ | 1 |
| Cho, EJ; Choi, R; Chung, CH; Hyun, MR; Kim, BH; Lee, ES; Lee, EY; Lee, MY; Naowaboot, J; Yang, YC | 1 |
| Fujita, E; Higo, S; Hirama, A; Iino, Y; Kaneko, T; Katayama, Y; Mii, A; Mishina, M; Ueda, K; Utsumi, K; Watanabe, Y; Yasuda, F | 1 |
| Liu, HR; Qi, MY; Su, YH; Yu, SQ | 1 |
| Baig, MA; Gawali, VB; Naik, SR; Patil, RR | 1 |
| Bigagli, E; Lodovici, M; Manni, ME; Raimondi, L; Zazzeri, M | 1 |
| Abd el-Latif, FF; Khalifa, M; Sayed, AA | 1 |
| He, G; Liao, Q; Luo, Y; Qing, Z; Zhang, Q; Zhou, Y | 1 |
| Gao, Y; Li, JH; Pan, QZ; Ren, M; Ren, SP; Ren, ZX; Shi, JH; Zhang, RR | 1 |
| Aslam, S; Friederich-Persson, M; Nordquist, L; Palm, F; Welch, WJ; Wilcox, CS | 1 |
| Gregorović, G; Končić, MZ; Lacković, G; Oršolić, N; Sirovina, D | 1 |
| Liang, H; Weng, JP; Xia, X; Xu, F; Yan, JH; Zhang, L; Zhao, Y; Zhu, YH | 1 |
| Dai, GL; Han, R; He, JK; Qin, ZH; Xie, Y; Zhu, LJ | 1 |
| Budhram, R; Clark, G; Lau-Cam, CA; Pandya, KG | 1 |
| Koo, JR; Vaziri, ND | 1 |
| Blazícek, P; Dzúrik, R; Gazdíková, K; Heidland, A; Schinzel, R; Sebeková, K; Spustová, V; Syrová, D | 1 |
| Bhatia, S; Kaur Gambhir, J; Madhava Prabhu, K; Shukla, R; Venkata Madhu, S | 1 |
| Cho, EJ; Nakagawa, T; Oowada, S; Yamabe, N; Yokozawa, T | 1 |
| Cao, HX; He, LQ; Shen, YJ | 1 |
| Imai, E; Moriyama, T; Oka, K; Ueda, H | 1 |
| Negrean, V; Sâmpelean, D; Suciu, I | 1 |
| Juneja, LR; Nakagawa, T; Okubo, T; Oya, T; Yokozawa, T | 1 |
| Hatai, A; Hori, Y; Nozawa, M; Sagai, M; Sato, S; Yamate, J | 1 |
| Chang, JM; Chen, HC; Chiu, YW; Kuo, HT; Kuo, MC | 1 |
| Anjaneyulu, M; Chopra, K; Kulkarni, SK; Sharma, S | 1 |
| Agarwal, R | 1 |
| Hanada, T; Kinoshita, Y; Kono, T; Saito, M; Satoh, I; Satoh, K; Shinbori, C; Suzuki, H; Uemasu, J; Yamada, M | 1 |
| Chopra, K; Kulkarni, SK; Sharma, S | 1 |
| Guo, SX; He, CY; Li, WD; Lin, SQ; Lin, ZB | 1 |
| Chiang, PF; Hsu, CC; Wu, WJ; Yin, MC | 1 |
| Li, L; Liu, H; Shen, J; Shi, Y; Wei, M; Xu, H | 1 |
| Agachan, B; Aydin, M; Ispir, T; Kebabcioglu, S; Ozkok, E; Ozturk, O; Yaylim, I; Yilmaz, H | 1 |
| Ishiyama, Y; Kobayashi, J; Muraki, E; Ohtake, K; Uchida, H | 1 |
| Bao, Y; Jia, R; Yuan, J | 1 |
| Das, UN | 1 |
| Cooper, ME; Dunlop, M; Jerums, G; Soulis-Liparota, T | 1 |
| Balabolkin, MI; Balashova, TS; Golega, EN; Kubatiev, AA; Rud'ko, IA | 1 |
| Bell, GM; Mason, H; McClelland, P; Patrick, AW; Stevenson, A; White, MC; Yaqoob, M | 1 |
| Kähler, W; Kuklinski, B; Plötz, C; Rühlmann, C | 1 |
| Nacitarhan, S; Ozben, T; Tuncer, N | 1 |
| Horie, K; Kurokawa, K; Maeda, K; Miyata, S; Miyata, T; Monnier, VM; Sakai, H; Sugiyama, S; van Ypersole de Strihou, C; Witztum, JL | 1 |
| Horie, K; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Sakai, H; Saotome, N; Suzuki, D; Uchida, K; Yagame, M; Yasuda, Y | 1 |
| Inagi, R; Kurokawa, K; Miyata, T; Sugiyama, S; Suzuki, D | 1 |
| Chen, X; Liu, H; Yi, M | 1 |
| Inoguchi, T; Kawano, K; Nawata, H; Ochi, H; Shimoike, T; Umeda, F | 1 |
| Hashimoto, M; Kasahara, J; Makino, H; Nagake, Y; Nakanishi, N; Satoh, M; Yamasaki, Y | 1 |
| Craven, PA; DeRubertis, FR; Liachenko, J; Melhem, MF | 1 |
| Futterweit, S; Mann, J; Pine, E; Trachtman, H; Valderrama, E | 1 |
| Collier, A; Leach, JP; Lowe, GD; Paterson, JR; Rumley, A; Rumley, AG; Small, M | 1 |
9 trial(s) available for malondialdehyde and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The Impact of Probiotic Soy Milk Consumption on Oxidative Stress Among Type 2 Diabetic Kidney Disease Patients: A Randomized Controlled Clinical Trial.
Topics: Adult; Aged; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet; F2-Isoprostanes; Female; Follow-Up Studies; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Probiotics; Soy Milk | 2017 |
Metabolic Response to Mulberry Extract Supplementation in Patients With Diabetic Nephropathy: a Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Glutathione; Humans; Inflammation Mediators; Insulin; Insulin Resistance; Iran; Lipids; Male; Malondialdehyde; Middle Aged; Morus; Oxidative Stress; Phytotherapy; Plant Extracts; Plants, Medicinal; Time Factors; Treatment Outcome | 2017 |
The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Albuminuria; Creatinine; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypothyroidism; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase; Thyroxine | 2018 |
The Effects of Probiotic Honey Consumption on Metabolic Status in Patients with Diabetic Nephropathy: a Randomized, Double-Blind, Controlled Trial.
Topics: Aged; Aged, 80 and over; Bacillus coagulans; Blood Glucose; C-Reactive Protein; Cholesterol; Diabetic Nephropathies; Double-Blind Method; Female; Honey; Humans; Insulin; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Probiotics | 2019 |
A study on correlation between oxidative stress parameters and inflammatory markers in type 2 diabetic patients with kidney dysfunction in north Indian population.
Topics: Biomarkers; Catalase; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glutathione Reductase; Humans; India; Interleukin-6; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Biomarkers; C-Reactive Protein; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Glutathione; Humans; Inflammation; Iran; Male; Malondialdehyde; Matrix Metalloproteinase 2; Middle Aged; Nitric Oxide; Oxidative Stress; Placebos; Prospective Studies; Selenium | 2016 |
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
Topics: Adolescent; Adult; Albuminuria; Antigen-Antibody Complex; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Prognosis; Risk Factors; Young Adult | 2012 |
[Diabetes mellitus--a free radical-associated disease. Results of adjuvant antioxidant supplementation].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Neurologic Examination; Oxygen; Selenium; Sodium Selenite; Thioctic Acid; Vitamin E | 1993 |
Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Topics: Adult; Biomarkers; Biopsy, Needle; Culture Techniques; Diabetic Nephropathies; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Function Tests; Lysine; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Protein Denaturation; Reference Values; Sensitivity and Specificity | 1999 |
116 other study(ies) available for malondialdehyde and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effect of Polygonatum odoratum ethanol extract on high glucose-induced tubular epithelial cell apoptosis and oxidative stress.
Topics: Apoptosis; Blotting, Western; Caspase 3; Cell Line; Diabetic Nephropathies; Epithelial Cells; Ethanol; Flow Cytometry; Glucose; Glutathione; Heme Oxygenase-1; Humans; Kidney Tubules; Malondialdehyde; NF-E2-Related Factor 2; Oxidative Stress; Plant Extracts; Polygonatum; Superoxide Dismutase | 2021 |
MiR-218 promotes oxidative stress and inflammatory response by inhibiting SPRED2-mediated autophagy in HG-induced HK-2 cells.
Topics: Apoptosis; Autophagy; Diabetic Nephropathies; Glucose; Humans; Inflammation; Interleukin-4; Interleukin-6; Malondialdehyde; MicroRNAs; Oxidative Stress; Reactive Oxygen Species; Repressor Proteins; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
[Protective effect and mechanism of electroacupuncture of "Biao-Ben" acupoints combination for mitochondrial dysfunction in diabetic nephropathy rats].
Topics: Actins; Acupuncture Points; Animals; Blood Glucose; Body Weight; Catalase; Cholesterol, HDL; Cholesterol, LDL; Collagen; Creatinine; Diabetic Nephropathies; Electroacupuncture; Eosine Yellowish-(YS); Fibronectins; Glutathione; Glycated Hemoglobin; Hematoxylin; Male; Malondialdehyde; Mitochondria; Nitrogen; Obesity; Rats; Rats, Wistar; Sirtuin 1; Streptozocin; Superoxide Dismutase; Triglycerides; Urease; Xanthine Oxidase | 2022 |
Effect of L-serine on oxidative stress markers in the kidney of streptozotocin-induced diabetic mice.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidative Stress; Streptozocin; Superoxide Dismutase | 2023 |
Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione Peroxidase; Glycation End Products, Advanced; Indoles; Inflammation; Malondialdehyde; Mesangial Cells; Oxidative Stress; Phenylcarbamates; Rats; Reactive Oxygen Species; Receptors, Leukotriene; Sulfonamides; Superoxide Dismutase; Tosyl Compounds; Tumor Necrosis Factor-alpha | 2019 |
Comparison Between Biomarkers of Kidney Injury, Inflammation, and Oxidative Stress in Patients with Diabetic Nephropathy and Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Inflammation; Male; Malondialdehyde; Matrix Metalloproteinase 2; Middle Aged; Oxidative Stress; Tumor Necrosis Factor-alpha | 2020 |
Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Carriers; Drug Delivery Systems; Fibrosis; Flavonoids; Insulin; Kidney; Malondialdehyde; Muramidase; Rats; Triglycerides | 2020 |
LncRNA ANRIL Silencing Alleviates High Glucose-Induced Inflammation, Oxidative Stress, and Apoptosis via Upregulation of MME in Podocytes.
Topics: Animals; Apoptosis; Diabetic Nephropathies; Disease Models, Animal; Gene Silencing; Glucose; Inflammation; L-Lactate Dehydrogenase; Malondialdehyde; Mice; Neprilysin; Oxidative Stress; Podocytes; RNA, Long Noncoding; Superoxide Dismutase; Up-Regulation | 2020 |
KCNQ1OT1/miR-18b/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells.
Topics: Cell Proliferation; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Gene Silencing; Glucose; HMGA2 Protein; Humans; Kidney; Malondialdehyde; Mesangial Cells; MicroRNAs; Oxidative Stress; Potassium Channels, Voltage-Gated; Reactive Oxygen Species; Superoxide Dismutase | 2021 |
Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice.
Topics: Albuminuria; Animals; Biomarkers; Blood Glucose; Body Weight; Chymases; Creatine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Gene Expression; Immunohistochemistry; Malondialdehyde; Mast Cells; Mice; NADPH Oxidase 4; RNA, Messenger | 2020 |
Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway.
Topics: Animals; Antioxidants; Apigenin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Delivery Systems; Heme Oxygenase (Decyclizing); Kidney; Lipids; Male; Malondialdehyde; Nanoparticles; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Signal Transduction; Streptozocin; Superoxide Dismutase | 2020 |
Vitexin, a fenugreek glycoside, ameliorated obesity-induced diabetic nephropathy via modulation of NF-κB/IkBα and AMPK/ACC pathways in mice.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; Apigenin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Gene Expression Regulation; Hypoglycemic Agents; I-kappa B Kinase; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; NF-kappa B; Obesity; Plant Extracts; Signal Transduction; Superoxide Dismutase; Trigonella; Tumor Necrosis Factor-alpha | 2021 |
Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury, inflammation, and extracellular matrix (ECM) deposition in an AMPK/mTOR-mediated autophagy axis.
Topics: AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Autophagy; Biflavonoids; Collagen; Diabetic Nephropathies; Extracellular Matrix; Fibronectins; Glucose; Humans; Inflammation; Malondialdehyde; Mesangial Cells; Oxidative Stress; Signal Transduction; Superoxide Dismutase; TOR Serine-Threonine Kinases | 2021 |
Alteration of oxidative stress and inflammatory cytokines induces apoptosis in diabetic nephropathy.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Gene Expression Regulation; Glutathione Peroxidase; Interleukin-6; Kidney; Male; Malondialdehyde; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |
The characterization, renoprotection and antioxidation of enzymatic and acidic exopolysaccharides from Hypsizigus marmoreus.
Topics: Agaricales; Animals; Antioxidants; Catalase; Diabetic Nephropathies; Fungal Polysaccharides; Glutathione Peroxidase; Kidney; Lipid Peroxidation; Malondialdehyde; Mice; Superoxide Dismutase | 2018 |
Antioxidative Effects of Tempol on Mitochondrial Dysfunction in Diabetic Nephropathy.
Topics: Animals; Antioxidants; Catalase; Cell Survival; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione Peroxidase; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Mitochondria; Oxidative Stress; Rats, Wistar; Spin Labels; Superoxide Dismutase | 2018 |
Yucca schidigera extract modulates the lead-induced oxidative damage, nephropathy and altered inflammatory response and glucose homeostasis in Japanese quails.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Biomarkers; Blood Glucose; Catalase; Coturnix; Deoxyguanosine; Diabetic Nephropathies; Glomerular Filtration Rate; Glucose Transporter Type 2; Glutathione; Homeostasis; Insulin; Kidney; Lead; Malondialdehyde; Metallothionein; Oxidative Stress; Pancreas; Plant Extracts; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Yucca | 2018 |
Malondialdehyde-modified LDL-related variables are associated with diabetic kidney disease in type 2 diabetes.
Topics: Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Malondialdehyde; Middle Aged; Retrospective Studies; Risk Factors | 2018 |
Anti-Diabetic and Anti-Nephritic Activities of Grifola frondosa Mycelium Polysaccharides in Diet-Streptozotocin-Induced Diabetic Rats Via Modulation on Oxidative Stress.
Topics: Acetylglucosaminidase; Animals; Blood Glucose; Blood Urea Nitrogen; Catalase; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet; Diet, High-Fat; Dose-Response Relationship, Drug; Functional Food; Glutathione Peroxidase; Grifola; Hypoglycemic Agents; Interleukin-2; Interleukin-6; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Polysaccharides; Rats, Wistar; Reactive Oxygen Species; Streptozocin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
Glycine mitigates renal oxidative stress by suppressing Nox4 expression in rats with streptozotocin-induced diabetes.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Glutathione; Glycine; Glycine Agents; Kidney; Male; Malondialdehyde; NADPH Oxidase 4; Oxidative Stress; Rats, Wistar; RNA, Messenger; Streptozocin | 2018 |
Dexpanthenol reduces diabetic nephropathy and renal oxidative stress in rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Inflammation; Kidney; Male; Malondialdehyde; Oxidative Stress; Pantothenic Acid; Rats, Wistar; Reactive Oxygen Species | 2019 |
Reduction of cellular stress is essential for Fibroblast growth factor 1 treatment for diabetic nephropathy.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Fibroblast Growth Factor 1; Fibrosis; Gene Expression Regulation; Humans; Kidney; Kidney Glomerulus; Malondialdehyde; Mice; Oxidative Stress | 2018 |
Protective Effects of Kaempferitrin on Advanced Glycation End Products Induce Mesangial Cell Apoptosis and Oxidative Stress.
Topics: Animals; Antioxidants; Apoptosis; Cell Line; Diabetic Nephropathies; Glycation End Products, Advanced; Kaempferols; Malondialdehyde; Mesangial Cells; Oxidative Stress; Rats; Signal Transduction; Superoxide Dismutase | 2018 |
Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Cell Proliferation; Cells, Cultured; Cytokines; Diabetic Nephropathies; Extracellular Matrix; Glucose; Humans; Malondialdehyde; Mesangial Cells; Reactive Oxygen Species; Superoxide Dismutase; Umbelliferones | 2019 |
Protective effect of a polysaccharide from Dipsacus asper Wall on streptozotocin (STZ)-induced diabetic nephropathy in rat.
Topics: Animals; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipsacaceae; Dose-Response Relationship, Drug; Fasting; Glutathione; Glycated Hemoglobin; Glycation End Products, Advanced; Lipids; Male; Malondialdehyde; Monosaccharides; Oxidative Stress; Polysaccharides; Rats; Rats, Wistar; Safety; Streptozocin; Superoxide Dismutase | 2019 |
Oxidative stress markers in cognitively intact patients with diabetic neuropathy.
Topics: Adult; Aged; Antioxidants; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glutathione Transferase; Humans; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Risk Factors | 2019 |
N
Topics: Adenosine; Alloxan; Animals; Blood Glucose; Cordyceps; Creatinine; Cytokines; Diabetic Nephropathies; Glutathione; Humans; Kidney; Male; Malondialdehyde; Oxidative Stress; Plant Extracts; Protective Agents; Rats; Superoxide Dismutase | 2019 |
Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors.
Topics: Animals; Deferiprone; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Iron Chelating Agents; Kidney; Male; Malondialdehyde; Pyridones; Rats; Rats, Wistar; Superoxide Dismutase; Tenascin | 2013 |
The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endorphins; Epithelial Cells; Glucagon; Glutathione Peroxidase; Hydrogen Peroxide; Insulin; Isoenzymes; Kidney; Losartan; Male; Malondialdehyde; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2013 |
Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; C-Reactive Protein; Chemokine CCL2; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Genistein; Kidney; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Inbred ICR; Oxidative Stress; Protein Kinase C; Protein Kinase C beta; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2013 |
The effects of Cetraria islandica and Pseudevernia furfuracea extracts in normal and diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Complex Mixtures; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Ethnopharmacology; Hyperglycemia; Hypoglycemic Agents; Injections, Intraperitoneal; Kidney; Lichens; Male; Malondialdehyde; Oxidative Stress; Parmeliaceae; Random Allocation; Rats, Sprague-Dawley; Renal Insufficiency; Streptozocin; Turkey | 2015 |
Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Deoxyguanosine; Diabetic Nephropathies; Female; Humans; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Neopterin; Oxidative Stress; Tumor Necrosis Factor-alpha | 2014 |
Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
Topics: Animals; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Catalase; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione; Kidney; Male; Malondialdehyde; Melatonin; Quercetin; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats.
Topics: Animals; Blood Glucose; Body Weight; Catalase; Cells, Cultured; Creatinine; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Glutathione Peroxidase; Kidney; Male; Malondialdehyde; Medicine, Chinese Traditional; Mesangial Cells; Oxidative Stress; Paeonia; Plant Extracts; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase | 2014 |
Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Urea Nitrogen; Carotenoids; Creatinine; Crocus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glutathione; Kidney; Malondialdehyde; Oxidative Stress; Protective Agents; Rats, Wistar; Xanthine Oxidase | 2015 |
Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Inflammation; Kidney; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Spironolactone; Streptozocin; Superoxides; Tetrazoles; Transforming Growth Factor beta | 2014 |
Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
Topics: Analysis of Variance; Animals; Blood Urea Nitrogen; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; DNA Primers; Dose-Response Relationship, Drug; Gene Expression Regulation; Glycation End Products, Advanced; Iridoids; Kidney; Malondialdehyde; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Molecular Structure; Oxidative Stress; Pancreas; Proteinuria; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Superoxide Dismutase | 2015 |
Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.
Topics: Acrylates; Angiotensin II; Animals; Blood Glucose; Catalase; Cholesterol; Collagen Type IV; Diabetic Nephropathies; Diet, High-Fat; Gene Expression Regulation, Enzymologic; Glutathione; Imidazoles; Kidney; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Thiophenes; Transforming Growth Factor beta1; Triglycerides | 2015 |
Beneficial effect of lycopene on anti-diabetic nephropathy through diminishing inflammatory response and oxidative stress.
Topics: Animals; Blood Glucose; Body Weight; Carotenoids; Cholesterol, HDL; Cholesterol, LDL; Diabetic Nephropathies; Fasting; Glutathione Peroxidase; Heme Oxygenase-1; Hypoglycemic Agents; Inflammation; Kidney; Kidney Diseases; Lipid Peroxidation; Lycopene; Male; Malondialdehyde; Mice; NF-kappa B; Oxidative Stress; Proteinuria; RNA, Messenger; Streptozocin; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Up-Regulation | 2015 |
Marker of lipid peroxidation related to diabetic nephropathy in Indonesian type 2 diabetes mellitus patients.
Topics: Adult; Aged; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Humans; Indonesia; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Prevalence; Spectrophotometry | 2015 |
Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease.
Topics: Adiponectin; Aged; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Early Diagnosis; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Predictive Value of Tests; Prognosis; Romania; Superoxide Dismutase | 2015 |
Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Kidney; Malondialdehyde; Oxidative Stress; Pentoxifylline; Rats; Streptozocin; Superoxide Dismutase; Tyrosine | 2015 |
Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib.
Topics: Animals; Blood Urea Nitrogen; Collagen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Glutathione; Hydroxyproline; Kidney; Male; Malondialdehyde; Oxidative Stress; Protein Kinase Inhibitors; Pyrimidines; Rats, Sprague-Dawley; Superoxide Dismutase; Toll-Like Receptor 4; Transcription Factor RelA | 2015 |
Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gene Expression; Inflammation; Kidney; Kidney Glomerulus; Lipid Metabolism; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxide Dismutase | 2016 |
Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Blood Glucose; Catalase; Cell Survival; Cells, Cultured; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Hyperglycemia; Kidney; Male; Malondialdehyde; Mice; Mice, Mutant Strains; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Ursodeoxycholic Acid | 2016 |
Chronic intermittent hypobaric hypoxia ameliorates diabetic nephropathy through enhancing HIF1 signaling in rats.
Topics: Animals; Cell Hypoxia; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Fibrosis; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Superoxide Dismutase; Transforming Growth Factor beta1 | 2016 |
The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model.
Topics: Aesculus; Animals; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Kidney Glomerulus; Male; Malondialdehyde; Plant Extracts; Rats, Sprague-Dawley; Seeds; Streptozocin; Transforming Growth Factor beta; Treatment Outcome | 2016 |
Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat.
Topics: Alloxan; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Glutathione; Inflammation; Kidney; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Stilbenes; Superoxide Dismutase | 2017 |
The protective effect of betulinic acid (BA) diabetic nephropathy on streptozotocin (STZ)-induced diabetic rats.
Topics: Animals; Betulinic Acid; Blood Glucose; Diabetic Nephropathies; Humans; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Triterpenes | 2017 |
Urocortin ameliorates diabetic nephropathy in obese db/db mice.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cell Line; Connective Tissue Growth Factor; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Eating; Extracellular Matrix; Female; Glycation End Products, Advanced; Immediate-Early Proteins; Insulin; Intercellular Signaling Peptides and Proteins; Kidney; Male; Malondialdehyde; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Sorbitol; Superoxide Dismutase; Time Factors; Transforming Growth Factor beta1; Urocortins | 2008 |
Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus.
Topics: Adolescent; Age of Onset; Albuminuria; alpha-Tocopherol; Antioxidants; beta Carotene; Biomarkers; Child; Child, Preschool; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidants; Oxidative Stress; Prospective Studies; Young Adult | 2009 |
Pioglitazone improves obesity type diabetic nephropathy: relation to the mitigation of renal oxidative reaction.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Blood Glucose; Cholesterol; Cystatin C; Cystatins; Diabetic Nephropathies; Glycated Hemoglobin; Guanine; Hypoglycemic Agents; Insulin; Kidney; Malondialdehyde; Obesity; Oxidation-Reduction; Phospholipids; Pioglitazone; Rats; Rats, Zucker; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazolidinediones; Transforming Growth Factor beta; Triglycerides | 2008 |
Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetophenones; Animals; Cytoprotection; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Down-Regulation; Drug Evaluation, Preclinical; Enzyme Inhibitors; Hypoglycemic Agents; Kidney; Male; Malondialdehyde; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Vascular Endothelial Growth Factor A | 2009 |
Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Blood Glucose; Blotting, Western; Cholesterol; Diabetic Nephropathies; Fatty Acids, Nonesterified; Fibronectins; Glycated Hemoglobin; Insulin; Male; Malondialdehyde; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proteinuria; Random Allocation; Rats; Rats, Inbred OLETF; Signal Transduction; Specific Pathogen-Free Organisms; Thioctic Acid; Transforming Growth Factor beta1 | 2009 |
The oxidative stress status in diabetes mellitus and diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Case-Control Studies; Catalase; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase | 2010 |
Depressive status does not alter renal oxidative and immunological parameters during early diabetic nephropathy in rats.
Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fluorescent Antibody Technique; Glutathione; Kidney; Lipid Peroxidation; Macrophages; Male; Malondialdehyde; Monocytes; Motivation; Motor Activity; Oxidative Stress; Psychoneuroimmunology; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxides | 2009 |
Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fat-fed and streptozotocin-treated rats.
Topics: Animals; Chaperonin 60; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Fats; Dinoprost; Heat-Shock Proteins; Histidine; HSP70 Heat-Shock Proteins; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar | 2010 |
Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Urea Nitrogen; Blotting, Western; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Heart; Kidney; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Myocardium; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Streptozocin | 2009 |
Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats.
Topics: Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucosides; Kidney; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Paeonia; Phytotherapy; Rats; Rats, Wistar | 2010 |
Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Cell Proliferation; Cells, Cultured; Collagen Type IV; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione Peroxidase; Glycation End Products, Advanced; Hypoglycemic Agents; Male; Malondialdehyde; Mangifera; Mesangial Cells; Rats; Rats, Wistar; Sorbitol; Superoxide Dismutase; Transforming Growth Factor beta1; Xanthones | 2010 |
Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Albuminuria; Animals; Carbon; Deoxyguanosine; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Fibronectins; Male; Malondialdehyde; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Oxides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Streptozocin | 2010 |
Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum; Hydroxyproline; Kidney; Male; Malondialdehyde; NADPH Oxidases; Oxidative Stress; Phenylbutyrates; Proteinuria; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2010 |
Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease.
Topics: Case-Control Studies; Chromosome Deletion; Cross-Sectional Studies; Diabetic Nephropathies; Female; Glutathione Transferase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Polymerase Chain Reaction; Renal Insufficiency, Chronic | 2010 |
[The effect of Astragalus membranaceus (Fisch) bge. on lipid peroxidation and NO level of myocardium from rats with diabetic nephropathy].
Topics: Animals; Astragalus propinquus; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Glutathione Peroxidase; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Nitric Oxide; Rats; Rats, Wistar; Superoxide Dismutase | 2001 |
Satureja khozestanica essential oil ameliorates progression of diabetic nephropathy in uninephrectomized diabetic rats.
Topics: Animals; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Gas Chromatography-Mass Spectrometry; Kidney Glomerulus; Malondialdehyde; Nephrectomy; Oils, Volatile; Organ Size; Phytotherapy; Rats; Satureja; Urea | 2011 |
Attenuation of glomerular injury in diabetic mice with tert-butylhydroquinone through nuclear factor erythroid 2-related factor 2-dependent antioxidant gene activation.
Topics: Animals; Antioxidants; Blood Glucose; Cell Nucleus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Hydroquinones; Hyperglycemia; Kidney Glomerulus; Male; Malondialdehyde; Mice; Microscopy, Electron, Transmission; NF-E2-Related Factor 2; Transcriptional Activation | 2011 |
17β-Estradiol and vitamin E modulates oxidative stress-induced kidney toxicity in diabetic ovariectomized rat.
Topics: Animals; Antioxidants; Blood Proteins; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Estradiol; Female; Kidney; Lipid Peroxidation; Malondialdehyde; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Serum Albumin; Vitamin E; Vitamins | 2011 |
Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice.
Topics: Administration, Oral; Aldehyde Reductase; alpha-Glucosidases; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Female; Glycoside Hydrolase Inhibitors; Hypertrophy; Hypoglycemic Agents; Kidney; Male; Malondialdehyde; Mice; Peptidyl-Dipeptidase A; Plants, Medicinal; Superoxide Dismutase; Time Factors | 2011 |
Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Biomarkers; Blood Glucose; Blood Urea Nitrogen; Body Weight; Catalase; Creatinine; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet; DNA; Dose-Response Relationship, Drug; Hypoglycemic Agents; Insulin Resistance; Kidney; Male; Malondialdehyde; Organ Size; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Seeds; Superoxide Dismutase; Trigonella | 2011 |
Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Culture Techniques; Cells, Cultured; Chemokine CCL2; Culture Media; Diabetic Nephropathies; Epithelial Cells; Glucose; Glutathione; Malondialdehyde; Mesangial Cells; Oxidative Stress; Rats; Reactive Oxygen Species; Superoxide Dismutase; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan | 2011 |
Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cells, Cultured; Chemokine CCL2; Collagen; Coumaric Acids; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gene Expression; Kidney; Malondialdehyde; Podocytes; Rats; Rats, Inbred OLETF; Reactive Oxygen Species; Transforming Growth Factor beta1 | 2011 |
Effects of olmesartan and imidapril on the plasma adiponectin, P-selectin, and MDA-LDL levels of diabetic nephropathy patients.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Imidazoles; Imidazolidines; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; P-Selectin; Tetrazoles | 2012 |
Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Collagen Type IV; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Flavonoids; Hydroxyproline; Kidney; Male; Malondialdehyde; Protective Agents; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Transforming Growth Factor beta1 | 2011 |
Protective effect of herbomineral formulation (Dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypoglycemic Agents; Kidney; Lipid Peroxidation; Malondialdehyde; Rats; Superoxide Dismutase | 2012 |
The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity.
Topics: Aldehyde Dehydrogenase; Angiotensin II Type 1 Receptor Blockers; Animals; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Losartan; Malondialdehyde; Monoamine Oxidase; Oxidative Stress; Protective Agents; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase | 2012 |
Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione; Interleukin-6; Kidney; Lipid Peroxidation; Malondialdehyde; Metformin; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Trigonella | 2012 |
Renal protective effect of Rosa laevigata Michx. by the inhibition of oxidative stress in streptozotocin-induced diabetic rats.
Topics: Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; I-kappa B Proteins; Kidney; Male; Malondialdehyde; Medicine, Chinese Traditional; NF-KappaB Inhibitor alpha; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rosa; Superoxide Dismutase; Transcription Factor RelA | 2012 |
Radix Astragali lowers kidney oxidative stress in diabetic rats treated with insulin.
Topics: Animals; Astragalus Plant; Blood Glucose; Blotting, Western; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Electrophoretic Mobility Shift Assay; Glutathione Peroxidase; Hypoglycemic Agents; Insulin; Interleukin-6; Kidney; Male; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2012 |
Acute knockdown of uncoupling protein-2 increases uncoupling via the adenine nucleotide transporter and decreases oxidative stress in diabetic kidneys.
Topics: Adenosine Diphosphate; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Knockdown Techniques; Guanosine Diphosphate; Ion Channels; Kidney Cortex; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial ADP, ATP Translocases; Mitochondrial Proteins; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Uncoupling Protein 2 | 2012 |
Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice.
Topics: Alloxan; Animals; Antioxidants; Croatia; Diabetic Nephropathies; Female; Humans; Kidney; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Plant Extracts; Propolis | 2012 |
[Protection effect and mechanism of Compound Xueshuantong Capsule on diabetic nephropathy rats].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Male; Malondialdehyde; Matrix Metalloproteinase 2; Nitric Oxide; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2012 |
Therapeutic potential of Naja naja atra venom in a rat model of diabetic nephropathy.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Elapid Venoms; Elapidae; Kidney; Male; Malondialdehyde; Organ Size; Rats; Rats, Wistar; Superoxide Dismutase | 2012 |
Comparative evaluation of taurine and thiotaurine as protectants against diabetes-induced nephropathy in a rat model.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Disease Models, Animal; Glutathione Disulfide; Glycated Hemoglobin; Insulin; Kidney; Male; Malondialdehyde; Nitric Oxide; Protective Agents; Rats; Rats, Sprague-Dawley; Taurine; Transforming Growth Factor beta1; Weight Gain | 2013 |
Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
Topics: Animals; Antioxidants; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Insulin; Lysine; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tyrosine | 2003 |
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetic Nephropathies; Female; Glomerulonephritis; Glycation End Products, Advanced; Homocysteine; Humans; Lipofuscin; Lysine; Male; Malondialdehyde; Middle Aged; Nephritis, Interstitial; Oxidative Stress; Polycystic Kidney Diseases; Ramipril; Severity of Illness Index; Statistics as Topic; Treatment Outcome | 2003 |
Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy.
Topics: Antioxidants; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Erythrocytes; Female; Glutathione; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nitrates; Nitric Oxide | 2003 |
A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Glycation End Products, Advanced; Kidney; Male; Malondialdehyde; Proteinuria; Rats; Rats, Wistar; Sorbitol; Streptozocin | 2004 |
[Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy].
Topics: 6-Ketoprostaglandin F1 alpha; Albuminuria; Animals; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Glutathione; Male; Malondialdehyde; Phytotherapy; Radioimmunoassay; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase; Thromboxane B2; Treatment Outcome | 2003 |
Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Glomerular Mesangium; Hypertrophy; Kidney Function Tests; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nifedipine; Organ Size | 2004 |
The oxidative stress in the development of diabetes chronic complications in the elderly.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; Ceruloplasmin; Cholesterol; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Intracranial Arteriosclerosis; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Oxidative Stress; Triglycerides | 2004 |
Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy.
Topics: Animals; Blood Glucose; Cholesterol; Diabetic Nephropathies; Dietary Fiber; Flavonoids; Galactans; Kidney; Kidney Function Tests; Male; Malondialdehyde; Mannans; Organ Size; Phenols; Plant Gums; Polyphenols; Rats; Rats, Wistar; Superoxide Dismutase; Tea | 2005 |
Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fabaceae; Flavonoids; Kidney Cortex; Macrophages; Male; Malondialdehyde; Phenols; Polyphenols; Protective Agents; Rats; Rats, Wistar; RNA, Messenger; Seeds; Streptozocin | 2005 |
Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy.
Topics: Adolescent; Adult; Animals; Antibodies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Space; Female; Humans; Immunohistochemistry; Kidney Glomerulus; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2005 |
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glutathione; Kidney; Kidney Function Tests; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Phenols; Phytoalexins; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Superoxide Dismutase; Terpenes | 2006 |
Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Diabetic Nephropathies; Energy Metabolism; Female; Humans; Inflammation; Interleukin-6; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Rest; Smoking; Tumor Necrosis Factor-alpha | 2005 |
N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Fatty Alcohols; Insulin; Male; Malondialdehyde; Protein Kinase C; Rats; Rats, Sprague-Dawley; Streptozocin; Transforming Growth Factor beta1 | 2006 |
Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Catalase; Curcuma; Curcumin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Glutathione; Kidney; Malondialdehyde; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Survival Rate | 2006 |
Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice.
Topics: Albuminuria; Analysis of Variance; Animals; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Immunohistochemistry; Kidney Glomerulus; Malondialdehyde; Mice; Mice, Inbred C57BL; Polysaccharides; Reishi; Streptozocin; Superoxide Dismutase; Transforming Growth Factor beta; Triglycerides | 2006 |
Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Cysteine; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drinking; Fibrosis; Glutathione; Kidney; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Weight Loss | 2007 |
Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress.
Topics: Animals; Antioxidants; Cell Cycle; Cell Line; Cell Proliferation; Cell Shape; Cornus; Diabetic Nephropathies; Flow Cytometry; Glutathione Peroxidase; Glycation End Products, Advanced; Glycosides; Iridoids; Malondialdehyde; Mesangial Cells; Microscopy, Fluorescence; Oxidative Stress; Rats; Reactive Oxygen Species; Superoxide Dismutase | 2006 |
Relationship between interleukin-8 and the oxidant-antioxidant system in end-stage renal failure patients.
Topics: Adult; Antioxidants; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Female; Glutathione; Humans; Interleukin-8; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidants | 2007 |
Dietary nitrite inhibits early glomerular injury in streptozotocin-induced diabetic nephropathy in rats.
Topics: Animals; Diabetic Nephropathies; Dietary Supplements; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitrites; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2007 |
Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Glutathione Peroxidase; Hypertrophy; Kidney Cortex; Kidney Glomerulus; Male; Malondialdehyde; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spironolactone; Superoxide Dismutase; Transforming Growth Factor beta1 | 2007 |
Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease.
Topics: Adult; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Humans; Hypertension; India; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Phospholipids | 1995 |
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
Topics: Albuminuria; Aldehyde Reductase; Animals; Antioxidants; Blood Glucose; Body Weight; Butylated Hydroxytoluene; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycated Hemoglobin; Glycosylation; Guanidines; Kidney Cortex; Male; Malondialdehyde; Oxidation-Reduction; Phthalazines; Probucol; Rats; Rats, Sprague-Dawley; Sorbitol | 1995 |
[The results of a comparative study of the lipid peroxidation processes and of the malondialdehyde level of the blood cells in patients with diabetic angiopathies and during insulin therapy].
Topics: Adult; Blood Platelets; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Erythrocyte Membrane; Humans; Insulin; Lipid Peroxidation; Malondialdehyde | 1994 |
Evidence of oxidant injury and tubular damage in early diabetic nephropathy.
Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Erythrocytes; Female; Glutathione Peroxidase; Humans; Kidney Tubules; Male; Malondialdehyde; Middle Aged; Reactive Oxygen Species; Superoxide Dismutase; Time Factors | 1994 |
Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fructosamine; Hexosamines; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Time Factors; Triglycerides | 1995 |
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Animals; Antibodies; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Kidney Glomerulus; Lipid Peroxidation; Lysine; Male; Malondialdehyde; Mice; Middle Aged; Nephrotic Syndrome; Norleucine; Pyrroles; Rabbits | 1997 |
Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Topics: Animals; Carbohydrate Metabolism; Cells, Cultured; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Glomerulus; Lipid Metabolism; Lipid Peroxidation; Lysine; Malondialdehyde; Oxidation-Reduction; Rats | 1999 |
[Observation on the content of plasma lipoperoxide and serum superoxide dismutase in NIDDM nephrosis patients].
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Nephrosis; Superoxide Dismutase | 1997 |
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Deoxyguanosine; Diabetes Mellitus; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Proteinuria; Renal Dialysis | 2000 |
Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Antioxidants; Cellulose; Deoxyguanosine; Diabetic Nephropathies; Female; Free Radical Scavengers; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Polymers; Renal Dialysis; Sulfones; Time Factors; Vitamin E | 2001 |
Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Mesangium; Glutathione; Hyperglycemia; Hypoglycemic Agents; Kidney Cortex; Malondialdehyde; Rats; Renal Insufficiency; Thioctic Acid; Transforming Growth Factor beta | 2002 |
Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
Topics: Animals; Blood Glucose; Body Weight; Chronic Disease; Diabetic Nephropathies; Growth; Immunoblotting; Immunohistochemistry; Kidney; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Survival Analysis | 2002 |
Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria.
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Biomarkers; Blood Coagulation; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Free Radicals; Humans; Linoleic Acid; Linoleic Acids; Malondialdehyde; Middle Aged; Regression Analysis | 1992 |